Spurious Hyperphosphatemia From Alteplase‐Treated Catheter: A Case Report and Literature Review
Open Access
- 27 July 2025
- journal article
- Published by Wiley in Clinical Case Reports
- Vol. 13 (8) , e70665
Abstract
Falsely elevated phosphate levels can occur when blood is drawn after alteplase use in dialysis catheters due to phosphorus‐containing excipients. Recognizing spurious hyperphosphatemia is important to prevent misdiagnosis, avoid inappropriate treatment changes, and ensure accurate phosphate monitoring in patients undergoing maintenance hemodialysis.Keywords
All Related Versions
This publication has 14 references indexed in Scilit:
- Relationship between serum phosphorus and mortality in non-dialysis chronic kidney disease patients: evidence from NHANES 2001–2018BMC Nephrology, 2024
- Phosphate intake, hyperphosphatemia, and kidney functionPflügers Archiv - European Journal of Physiology, 2022
- Management of Hyperphosphatemia in End-Stage Renal Disease: A New ParadigmJournal of Renal Nutrition, 2021
- Pseudohyperphosphatemia due to contamination with heparin: A case for cautionIndian Journal of Nephrology, 2014
- Pseudohyperphosphatemia in Waldenstrom′s MacroglobulinemiaIndian Journal of Nephrology, 2013
- Pharmacokinetics of alteplase in the treatment of ischaemic strokeExpert Opinion on Drug Metabolism & Toxicology, 2012
- Alteplase as Hemodialysis Catheter Locking Solution and Spurious HyperphosphatemiaThe Journal of Vascular Access, 2011
- Alteplase for the Management of Occluded Central Venous Access Devices: Safety ConsiderationsClinical Journal of Oncology Nursing, 2008
- Spurious hyperphosphatemia in a patient with alteplase-locked central venous catheterPediatric Nephrology, 2005
- Alteplase Versus Urokinase for Occluded Hemodialysis CathetersAnnals of Pharmacotherapy, 2003